Voyager Therapeutics Free Cash Flow (Quarterly) Analysis

Voyager Therapeutics Inc (VYGR)

5.65 -0.57 (-9.16%) USD | NASDAQ | Nov 15, 13:36

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
June 30, 2024	-32.55M
March 31, 2024	56.63M
December 31, 2023	-24.52M
September 30, 2023	-21.83M
June 30, 2023	-2.045M
March 31, 2023	123.06M
December 31, 2022	-13.18M
September 30, 2022	-16.48M
June 30, 2022	-19.73M
March 31, 2022	34.39M
December 31, 2021	10.85M
September 30, 2021	-21.37M
June 30, 2021	-22.94M
March 31, 2021	-21.67M
December 31, 2020	-25.53M
September 30, 2020	-29.89M
June 30, 2020	-23.08M
March 31, 2020	-30.30M
December 31, 2019	-26.74M

Date	Value
September 30, 2019	-22.75M
June 30, 2019	-33.62M
March 31, 2019	124.06M
December 31, 2018	-24.87M
September 30, 2018	-18.50M
June 30, 2018	-23.83M
March 31, 2018	47.00M
December 31, 2017	-15.00M
September 30, 2017	-16.30M
June 30, 2017	-16.80M
March 31, 2017	-17.24M
December 31, 2016	-16.96M
September 30, 2016	-10.69M
June 30, 2016	-9.911M
March 31, 2016	-9.947M
December 31, 2015	-9.678M
September 30, 2015	-7.009M
June 30, 2015	-7.482M
March 31, 2015	64.44M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-32.55M

Minimum

Jun 2024

123.06M

Maximum

Mar 2023

-5.628M

Average

-21.67M

Median

Mar 2021

Free Cash Flow (Quarterly) Benchmarks